Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.

Stocks

Market Closed - Sao Paulo 04:04:00 03/10/2026 HKT			5-day change	1st Jan Change
7.700 ^BRL	+8.76%		+4.76%	-15.66%

07-30	Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-07	Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	747.9	723.4	450	747.9	795.7	1,119
Change	-	-3.28%	-37.8%	66.21%	6.39%	40.68%
Enterprise Value (EV) ¹	1,277	1,482	1,291	1,698	1,813	2,286
Change	-	16.05%	-12.88%	31.53%	6.77%	26.1%
P/E	14.3x	9.25x	5.56x	10.6x	6.95x	9.42x
PBR	0.71x	0.67x	0.38x	0.6x	0.61x	0.83x
PEG	-	0.2x	1.62x	-0.8x	0.1x	2.46x
Capitalization / Revenue	0.14x	0.11x	0.06x	0.09x	0.08x	0.1x
EV / Revenue	0.23x	0.23x	0.17x	0.2x	0.18x	0.2x
EV / EBITDA	8.52x	9.11x	4.54x	5.74x	5.3x	5.65x
EV / EBIT	9.95x	10.9x	5.09x	6.5x	6.05x	6.53x
EV / FCF	-50.4x	-136x	-22.6x	-101x	11.3x	34.7x
FCF Yield	-1.98%	-0.73%	-4.42%	-0.99%	8.82%	2.88%
Dividend per Share ²	-	0.2706	0.1733	0.3858	0.575	-
Rate of return	-	4.59%	4.72%	6.32%	8.86%	-
EPS ²	0.4268	0.6377	0.6596	0.574	0.934	0.9697
Distribution rate	-	42.4%	26.3%	67.2%	61.6%	-
Net sales ¹	5,481	6,413	7,816	8,662	10,154	11,451
EBITDA ¹	149.9	162.7	284.2	295.6	342.1	404.5
EBIT ¹	128.3	136.3	253.8	261.1	299.7	350.1
Net income ¹	52.33	78.19	80.87	70.4	114.6	118.9
Net Debt ¹	528.9	758.4	840.9	950	1,017	1,167
Reference price ²	6.100	5.900	3.670	6.100	6.490	9.130
Nbr of stocks (in thousands)	122,611	122,611	122,611	122,611	122,611	122,611
Announcement Date	16/3/21	16/3/22	15/3/23	7/3/24	18/3/25	17/3/26

¹BRL in Million²BRL

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PROFARMA DISTRIBUIDORA DE PRODUTOS FARMACÊUTICOS S.A.	-	-	-	-	180M
ELI LILLY AND COMPANY	32.45x	11.78x	23.93x	0.61%	1,019B
JOHNSON & JOHNSON	28.48x	6.32x	17.7x	2.09%	617B
ABBVIE INC.	33.26x	7.78x	16.08x	2.64%	464B
MERCK & CO., INC.	104.98x	5.87x	24.89x	2.36%	356B
ROCHE HOLDING AG	18.81x	4.58x	11.36x	2.9%	333B
NOVARTIS AG	19.83x	5.17x	12.78x	3.09%	267B
ASTRAZENECA PLC	20.02x	4.17x	11.86x	2.13%	244B
AMGEN INC.	25.46x	6.66x	11.86x	2.5%	218B
GILEAD SCIENCES, INC.	-43.78x	6.39x	24.97x	2.27%	179B
Average	26.61x	6.52x	17.27x	2.29%	369.74B
Weighted average by Cap.	31.80x	7.61x	18.61x	1.96%